Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/25/2025

Immediate Insulin Initiation in Type 2 Diabetes

Rationale for Immediate Insulin Initiation

  • The American Diabetes Association guidelines explicitly recommend considering insulin therapy when A1C is ≥10%, particularly in patients already on multiple oral agents 1, 2
  • When combination oral therapy fails to achieve glycemic targets after 3 months, progression to insulin is indicated 2
  • The progressive nature of type 2 diabetes means that delaying insulin further will only worsen outcomes 1

Practical Insulin Initiation Strategy

  • Continue metformin 1000 mg twice daily, as it reduces insulin requirements and limits weight gain when combined with insulin 1, 3
  • Consider discontinuing glipizide when starting insulin to reduce hypoglycemia risk, as both agents increase this risk 2, 4
  • Continue Jardiance (empagliflozin) for its cardiovascular and renal benefits, which are independent of glycemic control 4, 3

Titration and Monitoring Plan

  • Instruct the patient to check fasting blood glucose daily for insulin titration 1
  • Provide education on hypoglycemia recognition, treatment, and when to contact you 5
  • Schedule follow-up within 1-2 weeks to assess glucose logs and adjust insulin doses 5
  • Recheck A1C in 3 months to evaluate treatment effectiveness 6

Critical Safety Considerations

  • Removing or reducing glipizide further decreases hypoglycemia risk 4
  • Provide glucose tablets and glucagon emergency kit with proper education 5
  • Emphasize that insulin is not a "failure" but a necessary progression in type 2 diabetes management 1
  • If patient develops ketosis or diabetic ketoacidosis symptoms, this would require immediate hospitalization and more intensive insulin therapy 7